Which ETFs own GLAXO.NS?
GlaxoSmithKline Pharmaceuticals Ltd — 5 ETFs hold it, worth $21.3M across 758.88K shares.
Holdings as of Aug 26, 2026 — portfolio reporting dates from the data provider; not live positions.
| # | ETF | Weight | Shares | Value | ETF AUM | Category | Today | |
|---|---|---|---|---|---|---|---|---|
| 1 | VEXC Vanguard Emerging Markets Ex-China ETF | 0.02% | 1.44K | $40.0K | $257.8M | Emerging Markets | +0.66% | |
| 2 | SCHE Schwab Emerging Markets Equity ETF | 0.01% | 50.67K | $1.6M | $12.91B | Emerging Markets | +0.42% | |
| 3 | VWO Vanguard FTSE Emerging Markets ETF | 0.01% | 601.45K | $16.7M | $162.30B | Emerging Markets | +0.56% | |
| 4 | VSGX Vanguard ESG International Stock ETF | 0.00% | 7.55K | $210.0K | $6.50B | Developed Markets | +0.01% | |
| 5 | VEU Vanguard FTSE All-World ex-US ETF | 0.00% | 97.78K | $2.7M | $95.90B | Developed Markets | -0.02% |
Coverage reflects the ETF portfolios loaded in our database; very small funds may not be swept yet. Market data delayed approximately 15–20 minutes unless otherwise indicated.